Skip to main content
. 2003 Jun;41(6):2391–2394. doi: 10.1128/JCM.41.6.2391-2394.2003

TABLE 2.

Comparative yields of clinically important microorganisms in BM and BD blood culture bottles containing samples from patients receiving antimicrobial therapy

Microorganism(s) No. of isolates detected in:
P value
Both bottles BM bottles only BD bottles only
Gram-positive cocci
    Staphylococcus aureus 22 10 7 NSa
    Coagulase-negative staphylococci 11 4 2 NS
    Streptococcus viridans group 5 0 0 NS
    Enterococcus spp.b 22 6 3 NS
Gram-negative bacilli
    Enterobacteriaceaec 19 4 2 NS
    Other gram-negative bacillid 2 3 2 NS
Anaerobic bacteriae 0 0 1 NS
Yeastsf 9 12 2 <0.025
All microorganisms 90 39 19 <0.01
a

NS, not significant (P > 0.05).

b

Includes 16 Enterococcus faecalis, 13 Enterococcus faecium, and 2 Enterococcus avium isolates.

c

Includes 15 Klebsiella pneumoniae, 3 Escherichia coli, 2 Proteus vulgaris, and 2 Serratia marcescens isolates and 1 isolate each of Enterobacter aerogenes, Proteus mirabilis, and Proteus rettgeri.

d

Includes three Burkholderia cepacia and two Acinetobacter baumannii isolates and one isolate each of Pseudomonas aeruginosa and Stenotrophomonas maltophilia.

e

Includes one Bacteroides thetaiotaomicron isolate.

f

Includes 14 Candida albicans, 5 Candida tropicalis, 2 Candida glabrata, and 2 Cryptococcus neoformans isolates.

HHS Vulnerability Disclosure